BACKGROUND: Intracellular deposition of tau protein is a hallmark lesion of Alzheimer's disease. Although it is known this event is secondary to excessive tau phosphorylation, the mechanisms involved remain unknown. We previously reported that the enzyme 5-Lipoxygenase (5LO) acts as a modulator of Aβ peptides formation in vivo, and here we investigate its influence on tau protein. METHODS: Tg2576 mice overexpressing neuronal 5LO were generated and its contribution to endogenous tau levels and metabolism investigated. RESULTS: Although no differences were noted in the levels of total tau for both groups, compared with controls, Tg2576 mice overexpressing 5LO had a significant increase in the phosphorylation state of tau at S396 and S396/S404, as recognized by the antibodies PHF-13 and PHF-1, respectively. By contrast, no phosphorylation changes were observed in other tau epitopes. This increase was associated with a significant elevation in cyclin dependent kinase-5 but not other kinases that have been involved in tau phosphorylation. Additionally, mice overexpressing 5LO had biochemical evidence of altered synaptic integrity because they manifested a reduction in PSD-95, synaptophysin and MAP2. CONCLUSIONS: This study demonstrates a new role for 5LO in regulating endogenous tau metabolism in the central nervous system and supports the hypothesis that its pharmacologic inhibition could be beneficial for Alzheimer's disease-related tau neuropathology.
BACKGROUND: Intracellular deposition of tau protein is a hallmark lesion of Alzheimer's disease. Although it is known this event is secondary to excessive tau phosphorylation, the mechanisms involved remain unknown. We previously reported that the enzyme 5-Lipoxygenase (5LO) acts as a modulator of Aβ peptides formation in vivo, and here we investigate its influence on tau protein. METHODS:Tg2576mice overexpressing neuronal 5LO were generated and its contribution to endogenous tau levels and metabolism investigated. RESULTS: Although no differences were noted in the levels of total tau for both groups, compared with controls, Tg2576mice overexpressing 5LO had a significant increase in the phosphorylation state of tau at S396 and S396/S404, as recognized by the antibodies PHF-13 and PHF-1, respectively. By contrast, no phosphorylation changes were observed in other tau epitopes. This increase was associated with a significant elevation in cyclin dependent kinase-5 but not other kinases that have been involved in tau phosphorylation. Additionally, mice overexpressing 5LO had biochemical evidence of altered synaptic integrity because they manifested a reduction in PSD-95, synaptophysin and MAP2. CONCLUSIONS: This study demonstrates a new role for 5LO in regulating endogenous tau metabolism in the central nervous system and supports the hypothesis that its pharmacologic inhibition could be beneficial for Alzheimer's disease-related tau neuropathology.
Authors: C Atzori; B Ghetti; R Piva; A N Srinivasan; P Zolo; M B Delisle; S S Mirra; A Migheli Journal: J Neuropathol Exp Neurol Date: 2001-12 Impact factor: 3.685
Authors: Shi Jie Liu; Ai Hong Zhang; Hong Lian Li; Qun Wang; Heng Mei Deng; William J Netzer; Huaxi Xu; Jian Zhi Wang Journal: J Neurochem Date: 2003-12 Impact factor: 5.372
Authors: Chih Hung Lo; Colin Kin-Wye Lim; Zhipeng Ding; Sanjula P Wickramasinghe; Anthony R Braun; Karen H Ashe; Elizabeth Rhoades; David D Thomas; Jonathan N Sachs Journal: Alzheimers Dement Date: 2019-10-22 Impact factor: 21.566
Authors: Grzegorz A Czapski; Kinga Czubowicz; Joanna B Strosznajder; Robert P Strosznajder Journal: Neurochem Res Date: 2015-12-16 Impact factor: 3.996
Authors: Johanna Michael; Julia Zirknitzer; Michael Stefan Unger; Rodolphe Poupardin; Tanja Rieß; Nadine Paiement; Horst Zerbe; Birgit Hutter-Paier; Herbert Reitsamer; Ludwig Aigner Journal: Int J Mol Sci Date: 2021-03-09 Impact factor: 5.923